Statins do not increase breast cancer risk in postmenopausal women
1. Statin use did not increase the risk of developing breast cancer among postmenopausal women. Evidence Rating Level: 2 (Good) ...
Tag: statin
2 Minute Medicine Rewind April 6, 2026
Drying Very Preterm Infants Before Plastic Wrapping at Birth: A Randomized Clinical Trial 1. Drying before plastic wrapping did not ...
Obicetrapib and ezetimibe combination therapy lowers LDL cholesterol in high-risk patients
1. FDC obicetrapib plus ezetimibe significantly decreased LDL cholesterol levels by 48.6% compared to placebo. 2. Serious adverse events were ...
Rosuvastatin may reduce risk of all-cause mortality and major adverse cardiovascular events compared with atorvastatin
1. In this multi-database retrospective cohort study, rosuvastatin was found to be associated with slightly decreased risk of all-cause mortality ...
Statin therapy reduces radiation-induced cardiotoxicity in patients with breast cancer receiving radiotherapy
1. In a cohort of individuals with invasive ductal carcinoma (IDC) that underwent breast-conserving surgery (BCS) and adjuvant breast radiotherapy, ...
Statins may improve tolerability of antidepressant therapy
1. In a large population-based cohort study, combination therapy of antidepressant therapy with a statin was associated with fewer antidepressant ...
Statin use for primary and secondary prevention is influenced by social determinants of health
1. In this cross-sectional study, rates of statin use for primary prevention were lower among non-Hispanic Black men and non-Mexican ...
Bempedoic acid reduces the risk of major adverse cardiovascular events
1. In this randomized controlled trial, bempedoic acid significantly reduced low-density lipoprotein (LDL) cholesterol levels in patients with increased cardiovascular ...
C-reactive protein may have superior prognostic value compared to low-density lipoprotein cholesterol for patients on statin therapy
1. High-sensitivity C-reactive protein increased the risk of all-cause mortality by two- to three-fold among all three randomized trials. 2. ...
Treat-to-target approach non-inferior to high-dose statin therapy in patients with coronary artery disease
1. Patients who received statin therapy using a treat-to-target approach (targeting LDL-cholesterol of 50-70mg/dL) did not have worse cardiovascular outcomes ...
